TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from Baseline of Perimeter edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Reporting Adverse Events by System Organ Class
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting a Solicited Injection Site or Systemic Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Evaluated Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in bleeding tendency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Duration of Direct Sunlight Exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diarrheal disease
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Hb levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain assessment using Verbal Descriptive Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression/distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in cancer-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on cancer mortality
Endpoint domain: Mortality/survival
Primary endpoint: Conditional event-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Smoking-Related Disease-Free Survival (S-DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Agreement in detecting fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Rodnan Skin Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Melanin Granule Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: AUC 0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: s-CTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom burden (patient outcome) supportive care screen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety assessment using Hospital Anxiety and Depression Scale (patient outcome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression assessment using Hospital Anxiety and Depression Scale (patient outcome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants to Learn New Information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of Participants to Identify Needed Interventions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of treated subjects free from incidences
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of responders to caffeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of immature platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from Baseline cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Side effects of deferasirox
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Days With a Respiratory Claim in 28 Days Prior to Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Stroop Color and Word Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Trail Making Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Letter Fluency Assessed by Change in FAS Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Category Fluency Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hopkins Verbal Learning Test (HVLT) - Revised Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brief Visual Memory Test - Revised (BVMT-R) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: in vivo physiological elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of Follow Up Imaging
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of Hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rates of Intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Imaging Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue elasticity measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in cases of malaria
Endpoint domain: Mortality/survival
Primary endpoint: Dental sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in prescription of Beta blocker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Subjects With Grade 3 Solicited Local Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects With Grade 3 Solicited General Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects With Grade 3 Haematological and Biochemical Levels
Endpoint domain: Adverse events/effects
Primary endpoint: Change of myocardial perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of achievement of 20% improvement in ACR criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total native kidney volume variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Functional health questionnaire (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Zarit Burden Interview
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Frequency and severity of treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-emergent serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: TEAEs leading to treatment discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Change of the objective International Knee Documentation Committee score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the subjective International Knee Documentation Committee score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of pink aesthetic score (PES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate (complete and qualified success)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder Status
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in progesterone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Clinical status at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants With Ocular and Non-ocular AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in total score of the Inventory of Depressive Symptomatology-Clinician Version (IDS-C30)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in total score of the Hamilton Rating Scale for Anxiety (HAM-A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Radiologic control of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-Specific Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diagnostic imaging quality of the prostate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid analgesic use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Treatment completion in jail
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reporting to assigned treatment modality after release
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of VmaxO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mortality in children under 5
Endpoint domain: Mortality/survival
Primary endpoint: Change in frequency of binge eating
Endpoint domain: Life impact
Endpoint subdomain: Eating behavior
Primary endpoint: Number of patients with different viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality of specimen from the lower respiratory tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Baseline-adjusted Forced Expiratory Volume in 1 Second (FEV1) AUC 0-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Hamilton Depression Rating Scale (HAM-D) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Insulin sensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Degree of aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharyngo-esophageal Segment (PES) opening size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of Mucin MUC5B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in attention scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Paediatric Anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma concentration of new antiretroviral drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracellular concentration of new antiretroviral drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Hemoglobin A1c (HbA1c) Levels (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fistula of pancreas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maternal HIV viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maternal retention in ART services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Treatment related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in postprandial blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of tuberculosis
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of malignancies
Endpoint domain: Adverse events/effects
Primary endpoint: ex vivo drug sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of clinically significant complications
Endpoint domain: Adverse events/effects
Primary endpoint: Physical activity practice in hours per week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adherence to oral chemotherapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Allograft rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of Cardiac Shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time taken to complete the surgical procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quantification of the vascularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Growth Hormone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time to Definitive Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency Department Length-of-Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in HbA1c (glycosylated hemoglobin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse effects of pegylated interferon and ribavirin
Endpoint domain: Adverse events/effects
Primary endpoint: Anaplastic Lymphoma Kinase (ALK) tumor rearrangement status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ovarian hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Endometrial histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Contact Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Exercise-Induced Leg Pain Questionnaire - British Version Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of occurred delayed cerebral ischaemia (DCI) per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Breastfeeding exclusivity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Proportion of Injections Delivered to the Intradermal Layer of the Skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Nasoenteric tube placement success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lens Fit Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in circulating endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Grade of neointimal hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Globe salvage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Global Assessment of Change (PGIC) Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success Rate in Achieving a 25(OH)D Level ≥30ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Re-intubation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With ≥ 1-grade Improvement in ATHS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence Rate of Vascular Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction and Vascular Death)
Endpoint domain: Mortality/survival
Primary endpoint: Systemic inflammation measured by c-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptoms associated with small airways disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients with subclinical cardiac abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of male partners receiving syphilis testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Differences in meal food intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in meal energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in meal energy density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: anatomic reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Standard of Neurological Classification for Spinal Cord Injury (ISNCSCI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting state fMRI functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting state fMRI brain parcels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hypertrophic scar reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blood-oxygen-level-dependent (BOLD) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Omega-3 fatty acid status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Shuttle run test (VO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of 'Sick' Days
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Motor Vehicle Crashes
Endpoint domain: Adverse events/effects
Primary endpoint: On-the-job Injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Seroconversion to Japanese Encephalitis Chimeric Virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who lost at least 3% of baseline body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coefficient of Fat Absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants Showing a 50% Reduction in Serum Prostate Specific Antigen (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in joint repositioning angle errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of patients remaining undetectable below 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of Participants Not Experiencing Relapse to Any Mood Episode
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of solicited adverse events after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of unsolicited adverse events of any severity 28 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious adverse events or new chronic medical conditions through the last study visit
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-4w,1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of bronchiectasis exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants Who Achieved HIV RNA <50 Copies/mL at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants That Died by Week 48
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Clinical Adverse Experiences (CAEs) at Week 48
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO-Five Well-being Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MACCE (cardiovascular death, non-fatal stroke or myocardial infarction)
Endpoint domain: Mortality/survival
Primary endpoint: Rehospitalization due to heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-rated sleep quality score changes
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PIL score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: True Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accuracy of non-invasive central blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence of Recurrent Respiratory Papillomatosis (RRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PTSD resilience-related brain connectivity pattern scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Connor-Davidson Resilience Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Posttraumatic Checklist-5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Responder Rate Greater Than 50% on the Numeric Rating Pain Scale Improvement
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Quantitative metrics of choline (Cho)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pigmentary Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Foot Health Status Questionnaire Pain Subscale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of measured anti-Xa activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Score for Pain (VAS) in the Immediate Post Operative Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes